Topical application of royal jelly has a healing effect on 5-fluorouracil-induced experimental oral mucositis in hamsters

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 30, Issue 2, 2008, Pages 103-106

  Suemaru, K ^a   Cui, R ^a   Li, B ^a   Watanabe, S ^a   Okihara, K ^b   Hashimoto, K ^b   Yamada, H ^b   Araki, H ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Yamada Apiculture Center Inc   (Japan)

Author keywords

5 Fluorouracil; Honey; Oral mucositis; Propolis; Royal jelly

Indexed keywords

FLUOROURACIL; PROPOLIS; ROYAL JELLY;

ABRASION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEEK POUCH; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HAMSTER; HONEY; MOUTH MUCOSA; MUCOSA INFLAMMATION; NONHUMAN;

ADMINISTRATION, TOPICAL; ANIMALS; CRICETINAE; FATTY ACIDS; FLUOROURACIL; GROWTH SUBSTANCES; HONEY; MESOCRICETUS; PROPOLIS; STOMATITIS; WOUND HEALING;

EID: 44349165061     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2008.30.2.1159655     Document Type: Article

References (33)

1. Scully, C., Sonis, S., Diz, P.D. Oral mucositis. Oral Dis 2006, 12: 229-41.
2. Mahood, D.J., Dose, A.M., Loprinzi, C.L. et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991, 9: 449-52.
3. Cascinu, S., Fedeli, A., Fedeli, S.L., Catalano, G. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil- induced stomatitis. Eur J Cancer B Oral Oncol 1994, 30: 234-6.
4. Schubert, M.M., Newton, R.E. The use of benzydamine HCl for the management of cancer therapy-induced mucositis: Preliminary report of a multicentre study. Int J Tissue React 1987, 9: 99-103.
5. Dodd, M.J., Larson, P.J., Dibble, S.L. et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis inpatients receiving chemotherapy. Oncol Nurs Forum 1996, 23: 921-7.
6. Saarilahti, K., Kajanti, M., Joensuu, T., Kouri, M., Joensuu, H. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: A double-blind prospective randomized phase III study. Int J Radiat Oncol Biol Phys 2002, 54: 479-85.
7. Spielberger, R., Stiff, P., Bensinger, W. et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004, 351: 2590-8.
8. Freytes, C.O., Ratanatharathorn, V., Taylor, C. et al. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation. Clin Cancer Res 2004, 10: 8318-24.
9. McDonnell, A.M., Lenz, K.L. Palifermin: Role in the prevention of chemotherapy- and radiation-induced mucositis. Ann Pharmacother 2007, 41: 86-94.
10. Sonis, S.T., Van Vugt, A.G., Brien, J.P. et al. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil Induced oral mucositis. Oral Oncol 1997, 33: 47-54.
11. McCormack, E.S., Borzillo, G.V., Ambrosino, C. et al. Transforming growth factor-beta 3 protection of epithelial cells from cycle-selective chemotherapy in vitro. Biochem Pharmacol 1997, 53: 1149-59.
12. Biswal, B.M., Zakaria, A., Ahmad, N.M. Topical application of honey in the management of radiation mucositis: A preliminary study. Support Care Cancer 2003, 11: 242-8.
13. Fujiwara, S., Imai, J., Fujiwara, M., Yaeshima, T., Kawashima, T., Kobayashi, K. A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J Biol Chem 1990, 265: 11333-7.
14. Okamoto, I., Taniguchi, Y., Kunikata, T. et al. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci 2003, 73: 2029-45.
15. Fujii, A., Kobayashi, S., Kuboyama, N. et al. Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats. Jpn J Pharmacol 1990, 53: 331-7.
16. Hepsen, I.F., Er, H., Cekic, O. Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthalmic Res 1999, 31: 426-31.
17. Gómez-Romero, M., Arráez-Román, D., Moreno-Torres, R., García-Salas, P., Segura-Carretero, A., Fernández- Gutiérrez, A. Antioxidant compounds of propolis determined by capillary electrophoresis-mass spectrometry. J Sep Sci 2007, 30: 595-603.
18. Speciale, A., Costanzo, R., Puglisi, S. et al. Antibacterial activity of propolis and its active principles alone and in combination with macrolides, beta-lactams and fluoroquinolones against microorganisms responsible for respiratory infections. J Chemother 2006, 18: 164-71.
19. Paulino, N., Teixeira, C., Martins, R. et al. Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis. Planta Med 2006, 72: 899-906.
20. Sonis, S.T., Tracey, C., Shklar, G., Jenson, J., Florine, D. An animal model for mucositis induced by cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1990, 69: 437-43.
21. Yamamura, K., Ohta, S., Yano, K., Yotsuyanagi, T., Okamura, T., Nabeshima, T. Oral mucosal adhesive film containing local anesthetics: In vitro and clinical evaluation. J Biomed Mater Res 1998, 43: 313-17.
22. Matsukura, T., Tanaka, H. Applicability of zinc complex of L-carnosine for medical use. Biochemistry (Moscow) 2000, 65: 817-23.
23. Matsuda, T., Ohno, S., Hirohata, S. et al. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behcet's disease: A randomised, double-blind, placebo-controlled study. Drugs R D 2003, 4: 19-28.
24. Rubenstein, E.B., Peterson, D.E., Schubert, M. et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004, 100: 2026-46.
25. Oshitani, T., Okada, K., Kushima, T. et al. Clinical evaluation of sodium alginate on oral mucositis associated with radiotherapy. Nippon Gan Chiryo Gakkai Shi 1990, 25: 1129-37.
26. Vardi, A., Barzilay, Z., Linder, N., Cohen, H.A., Paret, G., Brazilai, A. Local application of honey for the treatment of neonatal postoperative wound infection. Acta Paediatr 1998, 87: 429-32.
27. Efem, S.E.E., Udoh, K.T., Iwara, C.I. The antimicrobial spectrum of honey and its clinical significance. Infection 1992, 20: 227-9.
28. Sela, M., Maroz, D., Gedalia, I. Streptococcus mutant in saliva of normal subjects and neck and head irradiated cancer subjects after consumption of honey. J Oral Rehab 2000, 27: 269-70.
29. Mitsuhashi, H., Suemaru, K., Li, B., Cui, R., Araki, H. Evaluation of topical external medicine for 5-fluorouracil-induced oral mucositis in hamsters. Eur J Pharmacol 2006, 551: 152-5.
30. Kohno, K., Okamoto, I., Sano, O. et al. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 2004, 68: 138-45.
31. Mishima, S., Suzuki, K.M., Isohama, Y. et al. Royal jelly has estrogenic effects in vitro and in vivo. J Ethnopharmacol 2005, 101: 215-20.
32. Sonis, S.T., Van Vugt, A.G., McDonald, J. et al. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters. Cytokine 1997, 9: 605-12.
33. Andratschke, N.H., Nieder, C., Price, R.E., Rivera, B., Ang, K.K. Potential role of growth factors in diminishing radiation therapy neural tissue injury. Semin Oncol 2005, 32: 67-70.